Product Information

GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0821 per ML under NDC 59762505007. Its NADAC has been published 220 times since Sep 7, 2022.

FDA first approved this application on Mar 2, 2000. Its Orange Book therapeutic-equivalence code is AA.

GABAPENTIN 250 MG/5 ML SOLN

gabapentin
$0.0821per ML

Strength

250 mg/5mL

NDC

59762505007

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GABAPENTIN

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021129

FDA Approved

3/2/2000

TE Code

AA

On Market Since

7/1/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 220 times since Sep 7, 2022, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0821 per ML
All-time high$0.1379 (Sep 13, 2023)
All-time low$0.0768 (Nov 20, 2024)
52-week high$0.0887
52-week low$0.0821
Median price$0.0910
Average price$0.0997
Largest weekly change-23.5% (Apr 17, 2024)
Weeks tracked220
Tracking sinceSep 7, 2022

Price History

1W

-2.2%

1M

-6.3%

3M

-7.4%

6M

-2.1%

1Y

-4.1%

3Y

-29.9%

5Y

N/A

All

-6.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the gabapentin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by Mylan Pharmaceuticals Inc., is $0.0821 per ML (NDC 59762505007), effective Nov 18, 2026.

How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has declined 6.7%. It has been tracked across 220 weekly CMS publications since Sep 7, 2022.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?

Since Sep 7, 2022, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0768 (Nov 20, 2024) to a high of $0.1379 (Sep 13, 2023), with a median of $0.0910 per ML.

Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?

No other NADAC-published product currently shares the active ingredient and strength of GABAPENTIN 250 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GABAPENTIN 250 MG/5 ML SOLN?

GABAPENTIN 250 MG/5 ML SOLN (NDC 59762505007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.